Results 1 to 10 of about 35,578 (266)

Oral cholera vaccines and their impact on the global burden of disease. [PDF]

Hum Vaccin Immunother, 2019
With one-third of nations at risk of cholera, we can expect to experience massive, rapidly disseminated, and prolonged cholera outbreaks such as those recently experienced in Yemen and Haiti.
Wierzba TF.
europepmc   +4 more sources

An Update on Cholera Immunity and Current and Future Cholera Vaccines. [PDF]

Trop Med Infect Dis, 2021
Individual resistance to cholera infection and disease depends on both innate host factors and adaptive immunity acquired by a previous infection or vaccination.
Holmgren J.
europepmc   +2 more sources

Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers. [PDF]

Vaccines (Basel), 2020
Cholera is endemic in approximately 50 countries, primarily in Africa and South and Southeast Asia, and in these areas, it remains a disease associated with poverty.
Gabutti G, Rossanese A, Tomasi A, Giuffrida S, Nicosia V, Barriga J, Florescu C, Sandri F, Stefanati A.   +8 more
europepmc   +2 more sources

Allocation of Oral Cholera Vaccines in Africa. [PDF]

Vaccines (Basel)
Objectives: In this study, we examine the allocation of oral cholera vaccines (OCVs) across 25 African countries between 2013 and 2019. Methods: We constructed a dataset combining cholera outbreaks and requests, decisions, and deliveries of OCVs from the
Maffioli EM, Lu Y.
europepmc   +2 more sources

Prospective observational studies to provide confidence in the protection conferred by newer generation, inactivated oral cholera vaccines: a proposal. [PDF]

EClinicalMedicine
Summary: Inactivated oral cholera vaccines (OCVs) are a cornerstone of international efforts to control cholera, and are currently deployed from a global stockpile for the control of epidemics and endemic hotspots, as well as for humanitarian emergencies.
Clemens J, Deen J, Qadri F.
europepmc   +2 more sources

Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era. [PDF]

Hum Vaccin Immunother, 2017
Cholera remains an important but neglected public health threat, affecting the health of the poorest populations and imposing substantial costs on public health systems.
Desai SN, Pezzoli L, Alberti KP, Martin S, Costa A, Perea W, Legros D.   +6 more
europepmc   +2 more sources

An overview of VaxchoraTM, a live attenuated oral cholera vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2020
Cholera remains a public health threat among the least privileged populations and regions affected by conflicts and natural disasters. Together with Water, Sanitation and Hygiene practices, use of oral cholera vaccines (OCVs) is a key tool to prevent ...
Tarun Saluja, Vijayalaxmi V. Mogasale, Jean-Louis Excler, Jerome H. Kim, Vittal Mogasale   +4 more
doaj   +2 more sources

Plant-based edible vaccines: Can cholera be the case study in Africa? [PDF]

J Genet Eng Biotechnol
Vaccines are employed as a sanitary approach that is implemented to lessen the hurdles caused by infectious diseases on the safety of public health. A vaccine is biologically made from inactive components of microbes, to enhance immunity and as a defense
Siamalube B, Ehinmitan E, Kachenga L, Runo S, Ngotho M, Onguso J.   +5 more
europepmc   +2 more sources

Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries. [PDF]

BMC Public Health
Background The global resurgence of cholera, a diarrhoeal disease, has resulted in vaccine demand that exceeds the currently available supply resulting in global calls for next generation cholera vaccines.
Spasenoska D, Kahn AL, Bouhenia M, D'Cor NA, Lee JS, Park SE, Lynch J.   +6 more
europepmc   +2 more sources

Genomics of immune response to typhoid and cholera vaccines. [PDF]

Philos Trans R Soc Lond B Biol Sci, 2015
Majumder PP.
europepmc   +3 more sources